Accelerate Diagnostics Net Profit Margin 2010-2024 | AXDXQ

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Profit Margins Gross Margin Operating Margin EBITDA Margin Pre-Tax Margin Net Margin

Accelerate Diagnostics net profit margin from 2010 to 2024. Net profit margin can be defined as net Income as a portion of total sales revenue.

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Profit Margins Gross Margin Operating Margin EBITDA Margin Pre-Tax Margin Net Margin

Accelerate Diagnostics net profit margin from 2010 to 2024. Net profit margin can be defined as net Income as a portion of total sales revenue.

Related Stocks
Company Name	Market Cap
Intuitive Surgical (ISRG)	$188.5B
Thermo Fisher Scientific (TMO)	$162.6B
Edwards Lifesciences (EW)	$46.2B
Alcon (ALC)	$43.8B
IDEXX Laboratories (IDXX)	$43.5B
DexCom (DXCM)	$33.5B
IQVIA Holdings (IQV)	$28.6B
Mettler-Toledo (MTD)	$25.7B
STERIS (STE)	$22.7B
Waters (WAT)	$21B
SONOVA HOLDING (SONVY)	$17.7B
Hologic (HOLX)	$14.9B
Sysmex ADR (SSMXY)	$10.5B
Penumbra (PEN)	$9.4B
Masimo (MASI)	$9B
Globus Medical (GMED)	$7.8B
Glaukos (GKOS)	$6.1B
Teleflex (TFX)	$5.3B
Integer Holdings (ITGR)	$4.2B
TransMedics (TMDX)	$4.2B
PROCEPT BioRobotics (PRCT)	$3.3B
LivaNova (LIVN)	$2.5B
Veracyte (VCYT)	$2.2B
Nihon Kohden (NHNKY)	$2.1B
Elekta AB (EKTAY)	$2B
Alphatec Holdings (ATEC)	$1.7B
Artivion (AORT)	$1.4B
Pulse Biosciences (PLSE)	$1.2B
Paragon 28 (FNA)	$1.1B
OPKO Health (OPK)	$1.1B